Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.57 |
| ▸ | RELA | Q04206 | 1/20 | 0.57 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | PAM | P19021 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7390203 | 0.98 | L3MBTL1 (0.56) | GAALMNAABCC4TSHRPTGS1 | |
| SCHEMBL68930 | 0.93 | CYP4Z1 (0.57) | GAALMNATSHRL3MBTL1ALDH1A1 | |
| SCHEMBL7761585 | 0.89 | L3MBTL1 (0.49) | GAALMNAABCC4TSHRPTGS1 | |
| Benzene SCHEMBL28160801 | 0.89 | ALDH1A1 (0.68) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1873977 | 0.89 | ALDH1A1 (0.68) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL112999 | 0.89 | ALDH1A1 (0.68) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1332625 | 0.89 | ALDH1A1 (0.68) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL12126600 | 0.87 | CYP4Z1 (0.53) | LMNATSHRHTTL3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28243605 | 0.87 | ALDH1A1 (0.66) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL27679105 | 0.87 | ALDH1A1 (0.66) | LMNATSHRL3MBTL1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131972-A | Microsatellite stabilized colorectal cancer combination therapy based on PCSK9 inhibitors | 广东省人民医院 | 2025-06-13 | — | — | CN | claimed |
| CN-118987016-A | Application of antisense oligonucleotide in preparing medicament for treating glioma | 北京悦康科创医药科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-0171084-B1 | PHARMACEUTICAL OIL-IN-WATER TYPE MICRO-EMULSION | LEDERLE (JAPAN) LTD. (JP) | 1991-06-05 | — | — | EP | claimed |
| US-4647586-A | BIPHENYLACETIC ACID ESTER | LEDERLE (JAPAN), LTD. (JP) | 1987-03-03 | — | — | US | claimed |
| EP-0171084-A2 | Pharmaceutical oil-in-water type micro-emulsion | LEDERLE (JAPAN) LTD. (JP) | 1986-02-12 | — | — | EP | claimed |
| CN-122009643-A | Automatic feeding control system and control method for labeling machine | 台州奇优家居用品有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260069707-A1 | COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES | HALOZYME, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4702053-A1 | COMBINATION TREATMENT TARGETING SIRPA AND CLAUDIN 18.2 | LaNova Medicines Limited (CN) | 2026-03-04 | — | — | EP | disclosed |
| EP-4682164-A1 | NOVEL FUSION PROTEIN FOR TREATING AUTOIMMUNE DISEASES | Curogen Technology Co., Ltd. (KR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4662241-A1 | ANTIBODIES TARGETING LIV-1 AND USES THEREOF | LaNova Medicines Limited (CN) | 2025-12-17 | — | — | EP | disclosed |
| EP-4659068-A1 | DISPLAY SYSTEMS COMPRISING SPACERS DISPOSED BETWEEN FRAME AND DISPLAY BACK PANEL AND ASSOCIATED METHODS | Corning Incorporated (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-4656011-A2 | STABLE THIN FILM HEATERS BASED ON TRANSPARENT CONDUCTIVE COATINGS, STRUCTURES FORMED WITH THE HEATERS AND APPLICATIONS THEREOF | EKC TECHNOLOGY, INC. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-5231089-A | Anticonvulsants for nervous system disorders | UNIVERSITY OF FLORIDA (US) | 1993-07-27 | — | — | US | disclosed |
| WO-1993010794-A1 | COMPOSITION AND METHOD FOR IMPROVING ORAL BIOAVAILABILITY OF CARBAMAZEPINE | UNIVERSITY OF FLORIDA (US) | 1993-06-10 | — | — | WO | disclosed |
| US-5024998-A | Administering in aqueous solution with cyclodextrin derivative | UNIVERSITY OF FLORIDA (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0171084-B1 | PHARMACEUTICAL OIL-IN-WATER TYPE MICRO-EMULSION | LEDERLE (JAPAN) LTD. (JP) | 1991-06-05 | — | — | EP | disclosed |
| US-5017566-A | Redox systems for brain-targeted drug delivery | UNIVERSITY OF FLORIDA (US) | 1991-05-21 | — | — | US | disclosed |
| US-4647586-A | BIPHENYLACETIC ACID ESTER | LEDERLE (JAPAN), LTD. (JP) | 1987-03-03 | — | — | US | disclosed |
| EP-0171084-A2 | Pharmaceutical oil-in-water type micro-emulsion | LEDERLE (JAPAN) LTD. (JP) | 1986-02-12 | — | — | EP | disclosed |
| EP-0036684-A1 | Derivatives of 4-methyl-5-(2-aminoethyl)-thiomethyl-imidazole having therapeutic activity | Turconi, Franco (IT) | 1981-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069707-A1 | COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES | CD22, CD2, CD44 | GAA 1129/4885LMNA 2796/4885ABCC4 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.